Drug intelligence / Profile preview

Celoxone

Development stage
Unknown
Lead developer
Nutramedica
Modality
Small Molecules
Administration
Oral
01

Overview

Celoxone is a brand of cefalexin (cephalexin), a first-generation cephalosporin antibiotic marketed by Nutramedica. It is a small molecule that exerts its bactericidal effect by inhibiting bacterial cell wall synthesis. Specifically, it binds to and inactivates penicillin-binding proteins (PBPs) located on the inner membrane of the bacterial cell wall, which prevents the cross-linking of peptidoglycan chains. This disruption leads to cell lysis and death. Celoxone is indicated for the treatment of various bacterial infections, including upper respiratory tract infections, skin and soft tissue infections, and pediatric infections caused by susceptible gram-positive bacteria such as *Staphylococcus* and *Streptococcus* species. It is available in oral formulations including capsules for adults and suspensions or drops for pediatric use.

Brand names
Celoxone
Other names
cefalexincephalexin
02

Targets

PBP (Penicillin-binding protein family)

Beyond the preview

Go deeper on Celoxone.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Celoxone.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call